Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DrStockPick.com Stock Updates On NxStage Medical (NXTM), NXP Semiconductors (NXPI), MusclePharm (MSLP) and NVIDIA (NVDA).

drstock-2-3

signup3m

MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with eight performance products, has entered into a distribution agreement with TapouT to launch a MusclePharm apparel line that includes t-shirts, sweat suits, shorts and other active wear items.

TapouT currently has distribution in over 20,000 retail stores worldwide, as well as online, including a full line of fighter gear, men’s, women’s, youth and accessories. The complete MusclePharm apparel line will be available in 2011 through TapouT’s current retail distribution and on the TapouT website.

“We are very excited to partner with the leading, global mixed martial arts and UFC brand,” commented Cory Gregory, MusclePharm’s President. “This apparel opportunity with TapOuT will further increase MusclePharm’s brand awareness and expand MusclePharm’s market penetration through TapOuT’s extensive retail distribution network.”

MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed six products: ASSAULT, BATTLE FUEL, BULLET PROOF, COMBAT POWDER, RECON and SHRED MATRIX. Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma root– the “Russian Secret.” Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.

**************************************************************

NVIDIA (Nasdaq:NVDA) reports the expansion of its award-winning line of NVIDIA Quadro professional graphics solutions based on the NVIDIA Fermi architecture. The mid-range Quadro 2000 with 192 NVIDIA CUDA processing cores and the entry-level Quadro 600 with 96 CUDA processor cores now bring the computational and visualization benefits of the breakthrough Fermi architecture to all segments of the market.

NVIDIA awakened the world to the power of computer graphics when it invented the GPU in 1999. Since then, it has consistently set new standards in visual computing with breathtaking, interactive graphics available on devices ranging from tablets and portable media players to notebooks and workstations. NVIDIA's expertise in programmable GPUs has led to breakthroughs in parallel processing which make supercomputing inexpensive and widely accessible. The company holds more than 1,100 U.S. patents, including ones covering designs and insights which are fundamental to modern computing.

**************************************************************

NXP Semiconductors N.V. (NASDAQ: NXPI) has won two leading industry awards for its website and online marketing activity -- the 2010 WebAward for outstanding achievement in web development and MediaPost's Online Media, Marketing & Advertising (OMMA) Member's Choice Award for the best business-to-business integrated online campaign. Both awards recognize the outstanding efforts NXP has made to help simplify the lives of busy electronic designers while also educating them about pressing industry issues.

NXP Semiconductors N.V. provides High Performance Mixed Signal and Standard Product solutions that leverage its leading RF, Analog, Power Management, Interface, Security and Digital Processing expertise. These innovations are used in a wide range of automotive, identification, wireless infrastructure, lighting, industrial, mobile, consumer and computing applications. Headquartered in Europe, the company has approximately 28,000 employees working in more than 25 countries and posted sales of USD 3.8 billion in 2009.

**************************************************************

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, reported record financial results for the second quarter of 2010 ended June 30, 2010, with total revenue above the top end of its guidance range.

Net revenue for the second quarter of 2010 increased to $44.0 million, an increase of 21 percent when compared with revenue of $36.4 million for the second quarter of 2009. The increase was driven by strong performance across the Company's three markets: Home, Critical Care and In-Center.

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).